These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36393990)

  • 1. White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis.
    Rasmussen JØ; Nordholm D; Glenthøj LB; Jensen MA; Garde AH; Ragahava JM; Jennum PJ; Glenthøj BY; Nordentoft M; Baandrup L; Ebdrup BH; Kristensen TD
    Front Hum Neurosci; 2022; 16():1029149. PubMed ID: 36393990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis.
    Kristensen TD; Glenthøj LB; Raghava JM; Syeda W; Mandl RCW; Wenneberg C; Krakauer K; Fagerlund B; Pantelis C; Glenthøj BY; Nordentoft M; Ebdrup BH
    Schizophr Res; 2021 Nov; 237():192-201. PubMed ID: 34543833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep disturbances and the association with attenuated psychotic symptoms in individuals at ultra high-risk of psychosis.
    Nordholm D; Jensen MA; Glenthøj LB; Kristensen TD; Wenneberg C; Garde AH; Nordentoft M
    J Psychiatr Res; 2023 Feb; 158():143-149. PubMed ID: 36584492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms.
    Krakauer K; Ebdrup BH; Glenthøj BY; Raghava JM; Nordholm D; Randers L; Rostrup E; Nordentoft M
    Psychol Med; 2017 Nov; 47(15):2689-2707. PubMed ID: 28464976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis.
    Kristensen TD; Glenthøj LB; Ambrosen K; Syeda W; Raghava JM; Krakauer K; Wenneberg C; Fagerlund B; Pantelis C; Glenthøj BY; Nordentoft M; Ebdrup BH
    Acta Psychiatr Scand; 2021 Nov; 144(5):448-463. PubMed ID: 34333760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter maturation during 12 months in individuals at ultra-high-risk for psychosis.
    Krakauer K; Nordentoft M; Glenthøj BY; Raghava JM; Nordholm D; Randers L; Glenthøj LB; Ebdrup BH; Rostrup E
    Acta Psychiatr Scand; 2018 Jan; 137(1):65-78. PubMed ID: 29143980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study.
    Lunsford-Avery JR; LeBourgeois MK; Gupta T; Mittal VA
    Schizophr Res; 2015 May; 164(1-3):15-20. PubMed ID: 25818627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.
    Lunsford-Avery JR; Orr JM; Gupta T; Pelletier-Baldelli A; Dean DJ; Smith Watts AK; Bernard J; Millman ZB; Mittal VA
    Schizophr Res; 2013 Dec; 151(1-3):148-53. PubMed ID: 24094679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
    Bakker G; Caan MW; Schluter RS; Bloemen OJ; da Silva-Alves F; de Koning MB; Boot E; Vingerhoets WA; Nieman DH; de Haan L; Booij J; van Amelsvoort TA
    Psychol Med; 2016 Aug; 46(11):2299-311. PubMed ID: 27193339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis.
    Karlsgodt KH; Niendam TA; Bearden CE; Cannon TD
    Biol Psychiatry; 2009 Sep; 66(6):562-9. PubMed ID: 19423081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra-high risk for psychosis.
    Kristensen TD; Mandl RCW; Raghava JM; Jessen K; Jepsen JRM; Fagerlund B; Glenthøj LB; Wenneberg C; Krakauer K; Pantelis C; Nordentoft M; Glenthøj BY; Ebdrup BH
    Hum Brain Mapp; 2019 Dec; 40(18):5185-5201. PubMed ID: 31430023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White-matter markers for psychosis in a prospective ultra-high-risk cohort.
    Bloemen OJ; de Koning MB; Schmitz N; Nieman DH; Becker HE; de Haan L; Dingemans P; Linszen DH; van Amelsvoort TA
    Psychol Med; 2010 Aug; 40(8):1297-304. PubMed ID: 19895720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between White Matter Alterations and Pathophysiological Symptoms in Patients with Ultra-High Risk of Psychosis, First-Episode, and Chronic Schizophrenia.
    Waszczuk K; Tyburski E; Rek-Owodziń K; Plichta P; Rudkowski K; Podwalski P; Bielecki M; Mak M; Bober A; Misiak B; Sagan L; Michalczyk A; Kucharska-Mazur J; Samochowiec J
    Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis-A Randomized Clinical Trial.
    Kristensen TD; Ebdrup BH; Hjorthøj C; Mandl RCW; Raghava JM; Jepsen JRM; Fagerlund B; Glenthøj LB; Wenneberg C; Krakauer K; Pantelis C; Glenthøj BY; Nordentoft M
    Front Psychiatry; 2020; 11():873. PubMed ID: 33005161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hippocampal-thalamic white matter tract development and positive symptom course in individuals at ultra-high risk for psychosis.
    Bernard JA; Orr JM; Mittal VA
    NPJ Schizophr; 2015; 1():15009-. PubMed ID: 26120591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature, consequences, mechanisms, and management of sleep disturbances in individuals at-risk for psychosis.
    Fekih-Romdhane F; Hallit S; Cheour M; Jahrami H
    Front Psychiatry; 2022; 13():1011963. PubMed ID: 36203842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis.
    Collins M; Bartholomeusz C; Mei C; Kerr M; Spark J; Wallis N; Polari A; Baird S; Buccilli K; Dempsey SA; Ferguson N; Formica M; Krcmar M; Quinn AL; Wannan C; Oldham S; Fornito A; Mebrahtu Y; Ruslins A; Street R; Loschiavo K; McGorry PD; Nelson B; Amminger GP
    Psychiatry Res; 2024 Jul; 337():115966. PubMed ID: 38810536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis.
    Wang Y; Braam EE; Wannan CMJ; Van Rheenen TE; Chan RCK; Nelson B; McGorry PD; Yung AR; Lin A; Brewer WJ; Koutsogiannis J; Wood SJ; Velakoulis D; Pantelis C; Cropley VL
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1475-1485. PubMed ID: 34467451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in white matter evident before the onset of psychosis.
    Carletti F; Woolley JB; Bhattacharyya S; Perez-Iglesias R; Fusar Poli P; Valmaggia L; Broome MR; Bramon E; Johns L; Giampietro V; Williams SC; Barker GJ; McGuire PK
    Schizophr Bull; 2012 Nov; 38(6):1170-9. PubMed ID: 22472474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.